PATENT CLAIM ANALYSIS

Application Number: 15976135
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "211080"]

Abstract:
To provide a novel method for suppressing rejection after corneal transplantation. The method for suppressing rejection after corneal transplantation includes administering an effective amount of a Rho kinase inhibitor to a patient who needs it.

Claim (Index 6):
The method according to  claim 1 , wherein the Rho kinase inhibitor is administered in an ophthalmic preparation.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.37037
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15060927', '15534069', '12965615', '15511736', '12289748']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7188470458838635
- 35 USC 102 Novelty (BERT): 0.5100897138571516
- Combined Prediction Score: 0.6979713126811923
- Mean Citation Score: 171.514852
- Max Citation Score: 187.72162
- Similarity Product: 112.11284088058947

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test